Home

STEVE GORLIN

CIK 1033742 · Chairman of the Board · last filed 2023-12-06

STEVE GORLIN is a Chairman of the Board who has filed 87 SEC Form 4 insider transactions across 8 companies since 2011. The most recent filing, for BIVI, was dated Dec 6, 2023. Across all open-market trades the lifetime net is −$12.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.95M

Companies

8

Total Filings

87

Lifetime Open-Market Net

-$12.12M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIVI Director 715 $1.33 $951 $281.4K 12 2023-12-06
ImmunityBio, Inc. (NK) Delisted Director 92,592 — — -$13.52M 19 2020-06-11
POLARITYTE, INC. (PTE) Delisted Director 1,241 $0.24 $299 -$319.0K 3 2019-08-08
POLARITYTE, INC. (COOL) Delisted Director 23,333 $11.10 $259.0K $0 1 2017-11-13
Innoveren Scientific, Inc. (MDVXW) Delisted Director 1,640,704 — — $530.4K 9 2017-11-01
Innoveren Scientific, Inc. (MDVX.W) Delisted Director 961,503 — — $1.10M 3 2016-02-18
MDXG Director 446,288 $4.36 $1.95M -$193.8K 2 2013-05-30
Midatech Pharma US Inc. (DARA) Delisted Director — — — $0 2 2012-05-17

Recent Filings

87 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-12-06 BIVI Mixed −29,322 -$127.9K EDGAR
2023-12-01 BIVI Notice (144) −25,680 -$43.4K EDGAR
2023-12-01 BIVI Notice (144) −50,000 -$84.5K EDGAR
2023-09-07 BIVI Sell (S) −8,560 -$26.1K EDGAR
2023-09-05 BIVI Notice (144) −8,560 -$26.1K EDGAR
2023-01-18 BIVI Grant (A) +34,240 $0 EDGAR
2022-04-20 BIVI Grant (A) — $0 EDGAR
2021-03-05 BIVI Grant (A) — $0 EDGAR
2020-12-15 BIVI Buy (P) +2,430 $19.3K EDGAR
2020-12-15 BIVI Buy (P) +2,570 $20.5K EDGAR
Showing 1–10 of 87
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.